Latest hum. ProductsDetails
Product Name in the RMS: Levobupivacaïne Fresenius Kabi 2.5 mg/ml
MR Number: NL/H/2881/003
Date of outcome: 21.04.2014
| Type of application | |
|---|---|
|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Additional Strength/Form Generic Chemical Substance Prescription Only |
| Active Substances |
levobupivacaine hydrochloride 2,5 mg/ml |
| Form | solution for injection or infusion |
| MA Holder in the RMS |
Fresenius Kabi Deutschland GmbH Borkenberg 14 61440 Oberursel |
| RMS | Netherlands |
| Date of last change | 11.01.2019 |
| ATC-Code |
N01BB10 Levobupivacaine |
| CMS Country | Domestic Product Name |
|---|---|
| Belgium | Levobupivacaïne Fresenius Kabi 2,5mg/ml oplossing voor injectie/infusie |
| France | |
| Ireland | |
| Italy | |
| Portugal | |
| Slovenia | Levobupivakain Kabi 2,5 mg/ml raztopina za injiciranje/infundiranje |
| Spain | |
| United Kingdom |
| Documents | |
|---|---|
| PAR: | NL_H_2881_003_PAR.pdf (30.10.2014) |
| FinalSPC: | NL_H_2881_003_FinalSPC_1of5.pdf (15.10.2018) |
| FinalSPC: | NL_H_2881_003_FinalSPC_2of5.pdf (15.10.2018) |
| FinalSPC: | NL_H_2881_003_FinalSPC_3of5.pdf (15.10.2018) |
| FinalSPC: | NL_H_2881_003_FinalSPC_4of5.pdf (15.10.2018) |
| FinalSPC: | NL_H_2881_003_FinalSPC_5of5.pdf (15.10.2018) |
| FinalPL: | NL_H_2881_003_FinalPL_1of3.pdf (15.10.2018) |
| FinalPL: | NL_H_2881_003_FinalPL_2of3.pdf (15.10.2018) |
| FinalPL: | NL_H_2881_003_FinalPL_3of3.pdf (15.10.2018) |
| FinalLabelling: | NL_H_2881_003_FinalLabelling_1of2.pdf (15.10.2018) |
| FinalLabelling: | NL_H_2881_003_FinalLabelling_2of2.pdf (15.10.2018) |
